520 related articles for article (PubMed ID: 28712700)
81. Texture analysis in assessment and prediction of chemotherapy response in breast cancer.
Ahmed A; Gibbs P; Pickles M; Turnbull L
J Magn Reson Imaging; 2013 Jul; 38(1):89-101. PubMed ID: 23238914
[TBL] [Abstract][Full Text] [Related]
82. Textural radiomic features and time-intensity curve data analysis by dynamic contrast-enhanced MRI for early prediction of breast cancer therapy response: preliminary data.
Fusco R; Granata V; Maio F; Sansone M; Petrillo A
Eur Radiol Exp; 2020 Feb; 4(1):8. PubMed ID: 32026095
[TBL] [Abstract][Full Text] [Related]
83. Independent validation of machine learning in diagnosing breast Cancer on magnetic resonance imaging within a single institution.
Ji Y; Li H; Edwards AV; Papaioannou J; Ma W; Liu P; Giger ML
Cancer Imaging; 2019 Sep; 19(1):64. PubMed ID: 31533838
[TBL] [Abstract][Full Text] [Related]
84. Breast cancer molecular subtype classifier that incorporates MRI features.
Sutton EJ; Dashevsky BZ; Oh JH; Veeraraghavan H; Apte AP; Thakur SB; Morris EA; Deasy JO
J Magn Reson Imaging; 2016 Jul; 44(1):122-9. PubMed ID: 26756416
[TBL] [Abstract][Full Text] [Related]
85. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
[TBL] [Abstract][Full Text] [Related]
86. Can unenhanced MRI of the breast replace contrast-enhanced MRI in assessing response to neoadjuvant chemotherapy?
Cavallo Marincola B; Telesca M; Zaccagna F; Riemer F; Anzidei M; Catalano C; Pediconi F
Acta Radiol; 2019 Jan; 60(1):35-44. PubMed ID: 29742918
[TBL] [Abstract][Full Text] [Related]
87. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
88. Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.
Chen W; Giger ML; Newstead GM; Bick U; Jansen SA; Li H; Lan L
Acad Radiol; 2010 Jul; 17(7):822-9. PubMed ID: 20540907
[TBL] [Abstract][Full Text] [Related]
89. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
[TBL] [Abstract][Full Text] [Related]
90. The accuracy of breast MRI radiomic methodologies in predicting pathological complete response to neoadjuvant chemotherapy: A systematic review and network meta-analysis.
O'Donnell JPM; Gasior SA; Davey MG; O'Malley E; Lowery AJ; McGarry J; O'Connell AM; Kerin MJ; McCarthy P
Eur J Radiol; 2022 Dec; 157():110561. PubMed ID: 36308849
[TBL] [Abstract][Full Text] [Related]
91. Optimal reconstruction and quantitative image features for computer-aided diagnosis tools for breast CT.
Lee J; Nishikawa RM; Reiser I; Boone JM
Med Phys; 2017 May; 44(5):1846-1856. PubMed ID: 28295405
[TBL] [Abstract][Full Text] [Related]
92. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
[No Abstract] [Full Text] [Related]
93. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
[TBL] [Abstract][Full Text] [Related]
94. Evaluating pathologic response of breast cancer to neoadjuvant chemotherapy with computer-extracted features from contrast-enhanced ultrasound videos.
Zhang Q; Yuan C; Dai W; Tang L; Shi J; Li Z; Chen M
Phys Med; 2017 Jul; 39():156-163. PubMed ID: 28690116
[TBL] [Abstract][Full Text] [Related]
95. Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
Chamming's F; Ueno Y; Ferré R; Kao E; Jannot AS; Chong J; Omeroglu A; Mesurolle B; Reinhold C; Gallix B
Radiology; 2018 Feb; 286(2):412-420. PubMed ID: 28980886
[TBL] [Abstract][Full Text] [Related]
96. Computer-aided diagnosis for dynamic contrast-enhanced breast MRI of mass-like lesions using a multiparametric model combining a selection of morphological, kinetic, and spatiotemporal features.
Agliozzo S; De Luca M; Bracco C; Vignati A; Giannini V; Martincich L; Carbonaro LA; Bert A; Sardanelli F; Regge D
Med Phys; 2012 Apr; 39(4):1704-15. PubMed ID: 22482596
[TBL] [Abstract][Full Text] [Related]
97. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
Johansen R; Jensen LR; Rydland J; Goa PE; Kvistad KA; Bathen TF; Axelson DE; Lundgren S; Gribbestad IS
J Magn Reson Imaging; 2009 Jun; 29(6):1300-7. PubMed ID: 19472387
[TBL] [Abstract][Full Text] [Related]
98. Dynamic breast magnetic resonance imaging: pretreatment prediction of tumor response to neoadjuvant chemotherapy.
Dongfeng H; Daqing M; Erhu J
Clin Breast Cancer; 2012 Apr; 12(2):94-101. PubMed ID: 22169574
[TBL] [Abstract][Full Text] [Related]
99. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
100. Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.
Wu S; Weinstein SP; DeLeo MJ; Conant EF; Chen J; Domchek SM; Kontos D
Breast Cancer Res; 2015 May; 17():67. PubMed ID: 25986460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
